Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N J Slevin

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
The Journal of Laryngology and Otology|October 25, 2006
Should FDG-PET scanning be routinely used for patients with an unknown head and neck squamous primary?P Silva, P Hulse, A J Sykes, et al.
British Journal of Cancer|July 29, 1999
The lack of correlation between proliferation (Ki-67, PCNA, LI, Tpot), p53 expression and radiosensitivity for head and neck cancersT Björk-Eriksson, C M West, E Cvetskovska, et al.
The British Journal of Oral & Maxillofacial Surgery|November 13, 2010
Phase II study of cisplatin and imatinib in advanced salivary adenoid cystic carcinomaNiladri Ghosal, Kathleen Mais, Patrick Shenjere, et al.
European Journal of Cancer (Oxford, England : 1990)|May 12, 2009
Developing a CTCAEs patient questionnaire for late toxicity after head and neck radiotherapyK F Ho, D J J Farnell, J A Routledge, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 23, 2013
Nasopharyngeal carcinoma: a retrospective review of demographics, treatment and patient outcome in a single centreR J Colaco, G Betts, A Donne, et al.
The Journal of Laryngology and Otology|December 22, 1999
The diagnostic value of positron emission tomography (PET) with radiolabelled fluorodeoxyglucose (18F-FDG) in head and neck cancerN J Slevin, C D Collins, D L Hastings, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1996
A modelled comparison of the effects of using different ways to compensate for missed treatment days in radiotherapyJ H Hendry, S M Bentzen, R G Dale, et al.
International Journal of Radiation Oncology, Biology, Physics|February 11, 1998
Similar decreases in local tumor control are calculated for treatment protraction and for interruptions in the radiotherapy of carcinoma of the larynx in four centersC Robertson, A G Robertson, J H Hendry, et al.
European Journal of Nuclear Medicine|March 18, 1999
Does salivary gland scintigraphy predict response to pilocarpine in patients with post-radiotherapy xerostomia?R A Cooper, R A Cowan, S E Owens, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 31, 2012
Lack of prognostic effect of carbonic anhydrase-9, hypoxia inducible factor-1α and bcl-2 in 286 patients with early squamous cell carcinoma of the glottic larynx treated with radiotherapyC M Douglas, J M Bernstein, V E Ormston, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
The Journal of Laryngology and Otology|October 25, 2006
Should FDG-PET scanning be routinely used for patients with an unknown head and neck squamous primary?P Silva, P Hulse, A J Sykes, et al.
British Journal of Cancer|July 29, 1999
The lack of correlation between proliferation (Ki-67, PCNA, LI, Tpot), p53 expression and radiosensitivity for head and neck cancersT Björk-Eriksson, C M West, E Cvetskovska, et al.
The British Journal of Oral & Maxillofacial Surgery|November 13, 2010
Phase II study of cisplatin and imatinib in advanced salivary adenoid cystic carcinomaNiladri Ghosal, Kathleen Mais, Patrick Shenjere, et al.
European Journal of Cancer (Oxford, England : 1990)|May 12, 2009
Developing a CTCAEs patient questionnaire for late toxicity after head and neck radiotherapyK F Ho, D J J Farnell, J A Routledge, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 23, 2013
Nasopharyngeal carcinoma: a retrospective review of demographics, treatment and patient outcome in a single centreR J Colaco, G Betts, A Donne, et al.
The Journal of Laryngology and Otology|December 22, 1999
The diagnostic value of positron emission tomography (PET) with radiolabelled fluorodeoxyglucose (18F-FDG) in head and neck cancerN J Slevin, C D Collins, D L Hastings, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1996
A modelled comparison of the effects of using different ways to compensate for missed treatment days in radiotherapyJ H Hendry, S M Bentzen, R G Dale, et al.
International Journal of Radiation Oncology, Biology, Physics|February 11, 1998
Similar decreases in local tumor control are calculated for treatment protraction and for interruptions in the radiotherapy of carcinoma of the larynx in four centersC Robertson, A G Robertson, J H Hendry, et al.
European Journal of Nuclear Medicine|March 18, 1999
Does salivary gland scintigraphy predict response to pilocarpine in patients with post-radiotherapy xerostomia?R A Cooper, R A Cowan, S E Owens, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 31, 2012
Lack of prognostic effect of carbonic anhydrase-9, hypoxia inducible factor-1α and bcl-2 in 286 patients with early squamous cell carcinoma of the glottic larynx treated with radiotherapyC M Douglas, J M Bernstein, V E Ormston, et al.
Pageof 7